Ocugen, Inc. (OCGN) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Ocugen, Inc. (OCGN) short-term stock forecast for year 2025, month by month, and long-term OCGN price prediction for years 2025 to 2050. Check OCGN historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest OCGN news and headlines.
1 Month Prediction
$2.44 [213.29%]
3 Month Prediction
$2.93 [275.15%]
6 Month Prediction
$3.30 [323.39%]
1 Year Prediction
$3.38 [332.80%]
3 Year Prediction
$6.08 [679.85%]
5 Year Prediction
$8.79 [1026.98%]
About Ocugen, Inc.
Ocugen, Inc. is a biotechnology company based in Malvern, Pennsylvania. The company develops gene and cell therapies, as well as vaccines.
The company's lead product, OCU400, is a gene therapy in Phase 3 trials for retinal degeneration diseases. Other pipeline products include OCU410 for dry age-related macular degeneration and OCU410ST for Stargardt disease. It is also working on OCU200 for diabetic macular edema and diabetic retinopathy.
Plus, the company is working on vaccines such as OCU500 for COVID-19, OCU510 for seasonal flu, and OCU520, a combination flu and COVID-19 vaccine.
Ocugen, Inc. (OCGN) Historical Performance
Change
Since inception, OCGN has decreased by 99.85%. In the last 5 years, OCGN has risen from $0.45 to $0.78, a massive 73.33% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $12.67 and a low of $0.22.
52 Week Range
$0.495
$2.105
The current price $0.78 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
OCGN Stock Price History
Based on OCGN stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the OCGN stock has fallen from $0.22 - $1.83 to $0.78 - $0.78, which is down -89.18%. Currently, the stock follows downward trend.
Here, we have calculated stock range of OCGN, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $0.22 - $1.83 | $0.48 | -93.34 | 1 Year Change |
| 2021 | $1.77 - $12.67 | $7.76 | 7.66 | 2 Year Change |
| 2022 | $1.3 - $3.55 | $2.39 | -66.84 | 3 Year Change |
| 2023 | $0.37 - $1.27 | $0.63 | -91.26 | 4 Year Change |
| 2024 | $0.54 - $1.73 | $1.18 | -83.63 | 5 Year Change |
| 2025 | $0.78 - $0.78 | $0.78 | -89.18 | 6 Year Change |
OCGN Price Performance
6-Month Performance
OCGN stock dropped by 40.00% in the last six months.
1-Year Performance
The stock has trended downwards by 16.67% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 77.84%.
5-Year Performance
In the last 5 years, the stock has gone up by 73.33%.
According to Ocugen, Inc.'s historical data, below graph gives us the exact picture of how the OCGN stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
251.92% ↑
2021
148.63% ↑
2022
71.43% ↓
2023
55.77% ↓
2024
40.00% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Ocugen, Inc. (OCGN) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $1.14 M (Q3)
Revenue for Q3 ending 30th September, 2024 decreased 0.44% compared to Q2 ending 30th June, 2024.
Annual Revenue: $9.33 M (1Y)
Revenue for trailing 12 months increased 54.52% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone up from $43.00 thousand to $9.33 million, a 21,590.70% change.
Market Capitalization
Ocugen, Inc. has a market capitalization of $227.23M, which places OCGN in the micro-cap category.
Fundamental Analysis
EPS: $-0.04 (Q3), $-0.26 (1Y)
EPS increased 11.71% since last quarter, and decreased 31.58% since last year.
Net Income: $-12.97 M (Q3), $-63.08 M (1Y)
Net Income decreased 15.12% since last quarter, and decreased 27.33% since last year.
Free Cash Flow: $-11.78 M (Q3), $-72.53 M (1Y)
Free Cash Flow increased 13.00% since last quarter, and increased 12.39% since last year.
Net Profit Margin: -1141.73% (Q3), -676.29% (1Y)
Net Profit Margin decreased 14.74% since last quarter, and decreased 52.97% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for OCGN stock. These indicators help you understand Ocugen, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for OCGN stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.79 |
| SMA50 | $0.85 |
| SMA200 | $1.23 |
| RSI | 27.78 |
| Beta | 3.77 |
SMA20 > Current Price
This signals OCGN stock is in short-term bearish momentum.
SMA50 > Current Price
This signals OCGN stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals OCGN stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for OCGN stock is Bearish. Out of all indicators, 2 indicates bullish signals, 4 signals bearish trends and 3 gives neutral trends. The OCGN stock forecast was last updated on 26 January, 2025.
Ocugen, Inc. (OCGN) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $3.39 by the end of 2025, and can reach around $4.43 to $1.78 in 2026. And, the long-term forecast suggests that the stock may further jump to $5.88 - $5.01 in 2028, and $7.05 - $8.68 by 2031. So, the OCGN stock shows a strong upward trend in the next several years.
Short-term OCGN Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-02 | $2.44 | 212.82% |
| 2025-03 | $3.18 | 307.69% |
| 2025-04 | $2.93 | 275.64% |
| 2025-05 | $3.41 | 337.18% |
| 2025-06 | $3.33 | 326.92% |
| 2025-07 | $3.30 | 323.08% |
| 2025-08 | $3.08 | 294.87% |
| 2025-09 | $3.14 | 302.56% |
| 2025-10 | $3.16 | 305.13% |
| 2025-11 | $3.20 | 310.26% |
| 2025-12 | $3.39 | 334.62% |
In 2025, the OCGN stock price is expected to fluctuate between $2.44 and $3.41. According to the monthly forecast, the stock could rise to $3.39 by December 2024. If compared to the OCGN's current price, the stock could gain 334.62% by the end of this year.
Long-term OCGN Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $4.43 | $0.65 | $1.78 | 128.21% |
| 2027 | $3.58 | $6.78 | $8.08 | 935.9% |
| 2028 | $5.88 | $2.92 | $5.01 | 542.31% |
| 2029 | $12.22 | $8.75 | $11.16 | 1330.77% |
| 2030 | $6.65 | $10.71 | $8.30 | 964.1% |
| 2031 | $7.05 | $9.05 | $8.68 | 1012.82% |
| 2032 | $7.71 | $7.55 | $7.45 | 855.13% |
| 2033 | $6.78 | $7.88 | $13.52 | 1633.33% |
| 2034 | $19.07 | $8.64 | $10.68 | 1269.23% |
| 2035 | $10.52 | $13.11 | $15.18 | 1846.15% |
| 2036 | $24.89 | $17.69 | $11.74 | 1405.13% |
| 2037 | $14.70 | $15.15 | $23.63 | 2929.49% |
| 2038 | $30.75 | $20.33 | $23.16 | 2869.23% |
| 2039 | $11.48 | $13.16 | $11.65 | 1393.59% |
| 2040 | $20.16 | $11.91 | $27.18 | 3384.62% |
| 2041 | $18.74 | $23.98 | $13.88 | 1679.49% |
| 2042 | $23.52 | $29.50 | $25.56 | 3176.92% |
| 2043 | $16.21 | $30.86 | $30.71 | 3837.18% |
| 2044 | $22.20 | $10.69 | $23.59 | 2924.36% |
| 2045 | $35.28 | $35.32 | $37.54 | 4712.82% |
| 2046 | $41.00 | $40.23 | $19.41 | 2388.46% |
| 2047 | $12.95 | $35.80 | $40.86 | 5138.46% |
| 2048 | $30.55 | $20.29 | $41.35 | 5201.28% |
| 2049 | $26.08 | $41.22 | $40.75 | 5124.36% |
| 2050 | $26.08 | $44.08 | $40.32 | 5069.23% |
| 2051 | $40.66 | $34.09 | $23.12 | 2864.1% |
Ocugen, Inc. (OCGN) Stock Price Prediction & Forecast 2025
At the start of 2025, the OCGN stock was at $0.78. Today, it is trading at $0.78, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $3.39 by December 2025 with a 334.62% change.
Ocugen, Inc. (OCGN) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the OCGN stock. During this period, the OCGN's price is forecasted to shift from $4.43 to $8.30, which is 87.36% gain.
In 2026, the stock would possibly open at $4.43, descends to $0.65 by mid-year, and wraps up at $1.78, reflecting a 127.72% increase from today's price. Further moving to 2030, the stock can kick off the year at $6.65, drop to $10.71 by mid-year, and finish at $8.30, which is 964.39% change from current price.
Ocugen, Inc. (OCGN) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $7.05 to $27.18, which is up 1012.21%
In 2031, we can expect OCGN to fluctuate between $7.05 and $8.68, a shift indicating a 1012.21% gain by year-end compared to current price. And Until 2040, OCGN can likely vary from $20.16 to $27.18. By the end of 2040, the stock could record a 3384.20% rise from today's stock price.
Ocugen, Inc. (OCGN) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the OCGN stock can see an an upturn from $18.74 to $40.32 in this period. In 2041, the stock can experience a high of $23.98 by mid-year, closing the year at $13.88. This results in a 2974.57% increase from today.
Moving towards the end of 2050, OCGN is projected to open the year at $26.08. The stock may peak to $44.08 during mid-year and finish the year at $40.32. Compared to the stock's current price, this translates to an overall gain of 5069.79% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
OCGN Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| TNXP | Tonix Pharmaceuticals Holding Corp. | - | $0.38 | 16.09% ▲ | $161.03 ▲ |
| MRNA | Moderna, Inc. | - | $42.25 | 1.61% ▲ | $304.87 ▲ |
| IPA | ImmunoPrecise Antibodies Ltd. | - | $0.53 | 28.28% ▲ | $117.56 ▲ |
| NVAX | Novavax, Inc. | - | $9.31 | 15.86% ▲ | $74.57 ▲ |
| HOTH | Hoth Therapeutics, Inc. | - | $1.24 | 65.78% ▲ | $32.95 ▲ |
Last updated Jan 26 at 2:37 PM
OCGN : Buy, Sell Or Hold?
Analyst Ratings
Based on 4 analysts, 2 rated as a strong buy, 2 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for OCGN stock is Buy.
Expert Analysis
According to OCGN short-term and long-term forecast, Ocugen, Inc. shares are projected to go up by 5069.23%, and reach a value of $40.32 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, OCGN has recorded 6/30 green days, which reflects a 31.57894736842105% positivity rate with a price volatility of 0.05%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that OCGN stock is undervalued. So, Based on OCGN prediction and analysis, it may be the best time to sell OCGN stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "OCGN” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.